Mannkind (MNKD) Stock
Mannkind (MNKD) closed at $4.13 on Nov 13, 2026; its Tenet Score is 39 of 100 against 409 Healthcare peers.
17 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $4.13
- Nov 13, 2026
- Market cap
- $1.3B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 2.23 – 6.51
- low → high
- Tenet Score
- 39/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Mannkind Corp scores 39/100. Weak. Strongest on growth, financial health is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic c…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| AnaptysBio IncANAB | 50 | $1.4B |
| Ocular Therapeutix IncOCUL | 53 | $1.4B |
| Intellia Therapeutics IncNTLA | 43 | $1.4B |
| Mineralys Therapeutics IncMLYS | 55 | $1.4B |
| Innoviva IncINVA | 74 | $1.4B |
| Taysha Gene Therapies IncTSHA | 59 | $1.3B |
| AlvotechALVO | 44 | $1.3B |
| UroGen Pharma LtdURGN | 44 | $1.3B |
| Nektar TherapeuticsNKTR | 49 | $1.3B |
| Omeros CorporationOMER | 24 | $1.3B |
Common questions
What sector and industry is Mannkind in?
Mannkind is in the Healthcare sector and the Drugs industry.
What is Mannkind's Tenet Score?
Mannkind's Tenet Score is 39 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




